PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with ...

Targeted radioactive implants combined with chemotherapy are transforming inoperable pancreatic cancer into surgical ...

The SHARON trial is a phase 1 study testing a new treatment called GO-4 for patients with advanced pancreatic cancer who have ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could ...

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate ...

Garsorasib shrank tumours in nearly half of patients with KRAS G12C pancreatic cancer and showed manageable side effects.

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...